Axogen, Inc. — Director's Dealing 2024

Sep 5, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Axogen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2024-09-01

Reporting Person: Burke William P. Mr. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-09-01	Common Stock	M	11904	—	Acquired	28557	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-09-01	Restricted Stock Units	$	M	11904	Disposed		Common Stock (11904)	Direct

Footnotes

F1: This reflects the number of restricted stock units that vested on September 1, 2024.

F2: Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.

F3: Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on September 1, 2024, one year anniversary of the grant date.